{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:29:48Z","timestamp":1761006588529,"version":"build-2065373602"},"reference-count":37,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:00:00Z","timestamp":1760832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: Denosumab-related osteonecrosis of the jaw (DRONJ) is a serious complication in patients receiving long-term antiresorptive therapy for bone metastases from prostate cancer. While established risk factors include invasive dental procedures and poor oral health, the role of body composition, with a particular focus on sarcopenia and inflammatory biomarkers, remains unclear. This study aims to evaluate the association between skeletal muscle mass, fat distribution, and systemic inflammatory biomarkers with DRONJ risk in Asian prostate cancer patients with bone metastases. Methods: This retrospective study reviewed 64 patients who received denosumab between 2014 and 2023. Baseline CT scans were used to measure total psoas muscle index (TPI), visceral fat area (VFA), subcutaneous fat area (SFA), and body mass index (BMI). Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were calculated from blood counts. Group comparisons used the Wilcoxon rank-sum or chi-squared test, and correlations were assessed using Spearman\u2019s coefficient. Results: Twelve patients (18.8%) developed DRONJ, with a mean onset time of 20.3 months. The prevalence of sarcopenia was significantly higher in the DRONJ group compared to the non-DRONJ group (p = 0.0331). VFA, SFA, BMI, diabetes, and visceral obesity were not significant predictors. NLR, but not PLR, showed a significant negative correlation with TPI (\u03c1 = \u22120.2487, p = 0.0475), but no direct association with DRONJ, suggesting an indirect effect via sarcopenia. Conclusions: Sarcopenia may be an independent risk factor for DRONJ. Inflammatory biomarkers, particularly NLR, may contribute indirectly through reduced muscle mass. Body composition assessment may improve DRONJ risk stratification.<\/jats:p>","DOI":"10.3390\/diagnostics15202635","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T09:23:34Z","timestamp":1760952214000},"page":"2635","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sarcopenia as a Potential Risk Factor for Denosumab-Related Osteonecrosis of the Jaw in Asian Prostate Cancer Patients with Bone Metastases"],"prefix":"10.3390","volume":"15","author":[{"given":"Shinobu","family":"Mizushima","sequence":"first","affiliation":[{"name":"Department of Palliative Medicine, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9750-8243","authenticated-orcid":false,"given":"Daisuke","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan"},{"name":"Department of Urology, Koto Hospital, Tokyo 136-0072, Japan"},{"name":"Department of Molecular and Cellular Therapeutics, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Yanagida","sequence":"additional","affiliation":[{"name":"Department of Urology, Koto Hospital, Tokyo 136-0072, Japan"},{"name":"Department of Molecular and Cellular Therapeutics, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norikazu","family":"Kawae","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kashia","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Takagi","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Kajihara","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Koto Hospital, Tokyo 136-0072, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8128-3131","authenticated-orcid":false,"given":"Akio","family":"Mizushima","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan"},{"name":"Department of Molecular and Cellular Therapeutics, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar2167","article-title":"Role of RANKL inhibition in osteoporosis","volume":"9","author":"McClung","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1053\/hp.2000.6698","article-title":"Metastatic patterns of prostate cancer: An autopsy study of 1,589 patients","volume":"31","author":"Bubendorf","year":"2000","journal-title":"Hum. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","article-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: A randomised, double-blind study","volume":"377","author":"Fizazi","year":"2011","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1200\/JCO.19.01186","article-title":"Medication-Related Osteonecrosis of the Jaw: MASCC\/ISOO\/ASCO Clinical Practice Guideline","volume":"37","author":"Yarom","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joms.2009.10.010","article-title":"Osteonecrosis of the jaw in a patient on denosumab","volume":"68","author":"Aghaloo","year":"2010","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bjoms.2009.08.030","article-title":"Osteonecrosis of the jaws induced by anti-RANK ligand therapy","volume":"48","author":"Taylor","year":"2010","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the jaws\u20142022 update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.joms.2009.10.026","article-title":"Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction","volume":"68","author":"Saia","year":"2010","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/jcsm.12870","article-title":"Associations of osteoporosis and sarcopenia with frailty and multimorbidity among participants of the Hertfordshire Cohort Study","volume":"13","author":"Laskou","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jamda.2019.09.005","article-title":"The Joint Occurrence of Osteoporosis and Sarcopenia (Osteosarcopenia): Definitions and Characteristics","volume":"21","author":"Phu","year":"2020","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: Revised European consensus on definition and diagnosis","volume":"48","author":"Bahat","year":"2019","journal-title":"Age Ageing"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Lin, Y., Zhong, X., Lu, D., Yao, W., Zhou, J., Wu, R., and Feng, F. (2023). Association of visceral and subcutaneous fat with bone mineral density in US adults: A cross-sectional study. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-37892-6"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2147\/RMHP.S257677","article-title":"Total Psoas Area Index is Valuable to Assess Sarcopenia, Sarcopenic Overweight\/Obesity and Predict Outcomes in Patients Undergoing Open Pancreatoduodenectomy","volume":"13","author":"Xu","year":"2020","journal-title":"Risk Manag. Healthc. Policy"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1507\/endocrj.EJ23-0593","article-title":"Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan","volume":"71","author":"Ogawa","year":"2024","journal-title":"Endocr. J."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Chen, Z., Li, W.Y., Ho, M., and Chau, P.H. (2021). The Prevalence of Sarcopenia in Chinese Older Adults: Meta-Analysis and Meta-Regression. Nutrients, 13.","DOI":"10.3390\/nu13051441"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1532-3382(12)70046-5","article-title":"Antiresorptives and osteonecrosis of the jaw","volume":"12","author":"Yamashita","year":"2012","journal-title":"J. Evid. Based Dent. Pract."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","article-title":"Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma","volume":"29","author":"Henry","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_20","first-page":"447","article-title":"Safety of long-term denosumab therapy: Results from the open-label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer","volume":"24","author":"Stopeck","year":"2016","journal-title":"Support. Care Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"18317","DOI":"10.1002\/cam4.6429","article-title":"A real-world study on the prevalence and risk factors of medication-related osteonecrosis of the jaw in cancer patients with bone metastases treated with Denosumab","volume":"12","author":"Bracchi","year":"2023","journal-title":"Cancer Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3892\/ol.2017.6121","article-title":"Denosumab-related osteonecrosis of the jaw in a patient with bone metastases of prostate cancer: A case report and literature review","volume":"14","author":"Yoshimura","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"115650","DOI":"10.1016\/j.bone.2020.115650","article-title":"Incidence of and risk for osteonecrosis of the jaw in Korean osteoporosis patients treated with bisphosphonates: A nationwide cohort-study","volume":"143","author":"Kim","year":"2021","journal-title":"Bone"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.joms.2007.11.032","article-title":"Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: A case-control study","volume":"66","author":"Wessel","year":"2008","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e20230133","DOI":"10.1590\/1678-7757-2023-0133","article-title":"Obesity influences the development of bisphosphonate-induced osteonecrosis in Wistar rats","volume":"31","author":"Lima","year":"2023","journal-title":"J. Appl. Oral Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/oby.2003.74","article-title":"Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression","volume":"11","author":"Megias","year":"2003","journal-title":"Obes. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/jnci\/djm025","article-title":"Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: A population-based analysis","volume":"99","author":"Wilkinson","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"E1807","DOI":"10.1210\/jc.2013-2434","article-title":"Diabetes microvascular disease and the risk for bisphosphonate-related osteonecrosis of the jaw: A single center study","volume":"98","author":"Molcho","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.oooo.2012.05.017","article-title":"Intravenous bisphosphonate-related osteonecrosis of the jaw: Long-term follow-up of 109 patients","volume":"115","author":"Watters","year":"2013","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Kammerhofer, G., Vegh, D., B\u00e1nyai, D., V\u00e9gh, \u00c1., Joob-Fancsaly, A., Hermann, P., Geczi, Z., Hegedus, T., Somogyi, K.S., and Bencze, B. (2023). Association between Hyperglycemia and Medication-Related Osteonecrosis of the Jaw (MRONJ). J. Clin. Med., 12.","DOI":"10.3390\/jcm12082976"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1210\/jc.2006-2036","article-title":"Possible association between diabetes and bisphosphonate-related jaw osteonecrosis","volume":"92","author":"Khamaisi","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0022034510397196","article-title":"Risk factors for osteonecrosis of the jaws: A case-control study from the CONDOR dental PBRN","volume":"90","author":"Barasch","year":"2011","journal-title":"J. Dent. Res."},{"key":"ref_33","first-page":"e948","article-title":"Bone metabolism and clinical study of 44 patients with bisphosphonate-related osteonecrosis of the jaws","volume":"17","year":"2012","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.biocel.2003.09.006","article-title":"Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix","volume":"36","author":"McCarthy","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.acthis.2013.01.004","article-title":"Morphological changes induced by advanced glycation endproducts in osteoblastic cells: Effects of co-incubation with alendronate","volume":"115","author":"Gangoiti","year":"2013","journal-title":"Acta Histochem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1600-0757.2006.00168.x","article-title":"Diabetic periodontitis: A model for activated innate immunity and impaired resolution of inflammation","volume":"43","author":"Nassar","year":"2007","journal-title":"Periodontol. 2000"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2008-04-147884","article-title":"Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: A genome-wide single nucleotide polymorphism analysis","volume":"112","author":"Sarasquete","year":"2008","journal-title":"Blood"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/20\/2635\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T09:38:31Z","timestamp":1760953111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/20\/2635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,19]]},"references-count":37,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["diagnostics15202635"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics15202635","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,19]]}}}